# FDA Inspection 962557 - Glenmark Pharmaceuticals Ltd - February 26, 2016

Source: https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/ba4a8656-dfe3-4b6e-bdf3-dc6d2c4a55c2
Source feed: FDA_Inspections

> FDA Inspection 962557 for Glenmark Pharmaceuticals Ltd on February 26, 2016. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 962557
- Company Name: Glenmark Pharmaceuticals Ltd
- Inspection Date: 2016-02-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260403 - 2025-02-14](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/135e2ceb-8fc0-4f1b-85f4-7dd2405c8793)
- [FDA Inspection 1260403 - 2025-02-14](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/3c60fd16-c7cf-4f81-84b6-49d9b508a8a5)
- [FDA Inspection 1122868 - 2020-02-25](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/d660f074-743b-4d49-9676-d23b1a8f3af3)
- [FDA Inspection 1107098 - 2019-09-13](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/71212f99-083e-4703-bd7e-29af24033c10)
- [FDA Inspection 1053034 - 2018-05-24](https://www.globalkeysolutions.net/records/fda_inspections/glenmark-pharmaceuticals-ltd/d58dd996-cd4c-4c93-a806-807c622ee6c3)

Company: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-ltd/1e6c03ca-7a68-4506-9af3-70d64338538a

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c